Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16446329

Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2006 Feb 1
First author
Verheijen RH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 Feb 1;24(4):537-9. doi: 10.1200/JCO.2005.04.5138.
    note
    Source null
    related pmid
    16446325
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2006 Jul 20;24(21):3511-2. doi: 10.1200/JCO.2006.06.9658.
    note
    Source null
    related pmid
    16849774
    relationship
    Comment in

Authors and identifiers

  1. name
    Verheijen RH
    type
    Author
  2. name
    Massuger LF
    type
    Author
  3. name
    Benigno BB
    type
    Author
  4. name
    Epenetos AA
    type
    Author
  5. name
    Lopes A
    type
    Author
  6. name
    Soper JT
    type
    Author
  7. name
    Markowska J
    type
    Author
  8. name
    Vyzula R
    type
    Author
  9. name
    Jobling T
    type
    Author
  10. name
    Stamp G
    type
    Author
  11. name
    Spiegel G
    type
    Author
  12. name
    Thurston D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Verheijen RH
    type
    Author
  2. name
    Massuger LF
    type
    Author
  3. name
    Benigno BB
    type
    Author
  4. name
    Epenetos AA
    type
    Author
  5. name
    Lopes A
    type
    Author
  6. name
    Soper JT
    type
    Author
  7. name
    Markowska J
    type
    Author
  8. name
    Vyzula R
    type
    Author
  9. name
    Jobling T
    type
    Author
  10. name
    Stamp G
    type
    Author
  11. name
    Spiegel G
    type
    Author
  12. name
    Thurston D
    type
    Author
bibliography ids
  1. nci-bib-5bc33fd13b91e87d5877c216
book metadata
content sha256
42428e0ecad427c97d3b2176c61f23048548e92103fbc1b3ae54aa3290f7c447
document type
citation
dois
  1. 10.1200/JCO.2005.02.5973
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:16446329
immutable id
pubmed:16446329@42428e0ecad427c97d3b2176c61f23048548e92103fbc1b3ae54aa3290f7c447
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
4
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
571-8
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2006 Feb 1;24(4):537-9. doi: 10.1200/JCO.2005.04.5138.
    note
    Source null
    related pmid
    16446325
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2006 Jul 20;24(21):3511-2. doi: 10.1200/JCO.2006.06.9658.
    note
    Source null
    related pmid
    16849774
    relationship
    Comment in
outcomes validated
false
pmid
16446329
provenance
batch id
a181c30258a88d182e78
provider
NCBI PubMed ESummary
record sha256
32cecea75d8f3d9564cfa7439068adef1d7df2eed28b056b3702e1e2909860d2
response sha256
558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
retrieved at
2026-09-09T23:46:03.896343+00:00
publication date
display
2006 Feb 1
precision
day
year
2006
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/16446329/
title
Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.

Preserved source evidence · Not medical advice